TNF and inflammatory bowel disease: Overall, given its function in TNF- and TLR-mediated inflammation, Sam68 may prove a potential therapeutic target for the treatment of UC and potentially IBD with fewer side effects than the global TNF inhibition currently recommended in the clinic for IBD.